Introduction
Pharmaceutical plastic jars are rigid containers specifically designed to protect solid and semi-solid drugs, nutraceuticals and food supplements from contamination, moisture and light, while ensuring safe dosing and patient usability. They have become a core solution for tablets, capsules, powders and creams thanks to their robustness, versatility and compatibility with automated filling lines.
Screen-printing is a direct printing technique in which ink is transferred through a mesh onto the jar surface, creating durable, high-opacity graphics and legally required information. It is widely used on rigid plastic containers because it delivers sharp, long-lasting decoration on curved shapes, even with challenging formulations and frequent handling.
In this context, “Made in Italy” stands for refined industrial design, manufacturing craftsmanship and a mature regulatory culture in pharmaceutical packaging. Steba embodies this combination, offering Italian-made pharmaceutical plastic jars, in-house screen-printing and integrated packaging solutions from a single specialist partner.
The following sections will explore key material and design requirements, the fundamentals of screen-printing technology, regulatory and quality compliance, and the branding and supply-chain advantages of collaborating with Steba in Italy for complete pharmaceutical jar packaging projects.
Fundamentals of Pharmaceutical Plastic Jars
Key Performance Requirements for Pharma Jars
Pharmaceutical plastic jars must create a controlled micro-environment for tablets, capsules, and powders. Adequate barrier properties limit moisture ingress, oxygen permeation, and, when combined with suitable pigments, light exposure that can degrade actives. At the same time, jars need sufficient mechanical resistance to withstand drop tests, vibration during transport, and repeated opening/closing without stress cracking.
Closures are integral to performance: child-resistant caps, tamper-evident bands, and induction or pressure seals must mate precisely with the jar neck to maintain tightness and safety. Steba supports technical selection of jar formats and closure systems according to dosage form (e. g., hygroscopic tablets vs. coated capsules) and distribution channel, from hospital use to e-commerce shipping, ensuring that protection and usability remain consistent throughout the product’s lifecycle.
Material Choices and Their Implications
For solid oral forms, HDPE and PP dominate thanks to their chemical resistance to common excipients, low weight, and established recyclability streams. PET is preferred when higher transparency and a more “premium” visual impact are required, for instance to show capsule color coding. Each resin presents different surface energy, influencing ink wetting and adhesion during screen-printing.
Steba can supply jars in HDPE, PP, or PET and apply surface pre-treatments such as flame or corona to raise surface tension, stabilizing ink anchorage and improving resistance to abrasion, alcohol wipes, and routine handling in pharmacies.
Designing Jars for Printability and Usability
From a printing standpoint, cylindrical or gently curved bodies allow stable screen contact and precise registration, essential for multi-color dosage instructions or multilingual panels. Steba works to keep ribs, deep recesses, and side seams outside the designated print window so graphics remain sharp and legible, even at small font sizes.
Ergonomics also matters: jar diameter must permit a secure grip, while neck and thread design influence opening torque and ease of use for elderly or arthritic patients. Steba collaborates with pharmaceutical companies to co-design body profiles and shoulder angles that reconcile patient-friendly handling, regulatory panel space, and the tolerances required for repeatable screen-printing on automated lines.
Screen-Printing Technology for Pharmaceutical Plastic Jars
How Screen-Printing Works on Plastic Jars
Screen-printing transfers ink through a tensioned mesh onto rigid plastic jars, making it ideal for cylindrical, stable containers used in pharma. The process starts with screen preparation, where a photosensitive emulsion defines open areas for ink passage. During printing, controlled ink deposition is achieved as a squeegee forces ink through the mesh while the jar rotates in perfect synchrony, ensuring 360° coverage. Curing then fixes the ink, forming a continuous, robust film.
Mesh count determines line sharpness and ink thickness: higher counts for fine dosage text and barcodes, lower counts for dense logos or hazard bands. Squeegee pressure and speed further refine edge definition and coverage, especially on textured or slightly curved walls. Machines must adapt to different diameters, heights, and wall thicknesses to avoid distortion or misregistration. Steba’s Italian lines are engineered with programmable axes and format-specific tooling, allowing expert technicians to set and validate parameters per jar format, guaranteeing repeatable results across large GMP batches.
Ink Systems and Curing for Pharmaceutical Use
Pharmaceutical jars typically use UV-curable, solvent-based, or dedicated low-migration inks. These systems are selected for resistance to alcohol-based disinfectants, abrasion from repeated handling, and contact with secondary packaging. UV curing offers rapid, energy-efficient hardening with excellent adhesion, while thermal curing can enhance flexibility on certain polymers; both influence final gloss, scratch resistance, and line integrity, as well as line speed.
Steba qualifies ink systems in accordance with pharma expectations: low odour, controlled extractables, and compatibility with relevant regulatory frameworks. Each ink–plastic pairing undergoes adhesion, rub, and chemical-resistance tests before industrialisation, ensuring stable, legible printing throughout the product’s shelf life.
Advantages of Screen-Printing vs Labels and Sleeves
Direct screen-printing removes the risk of label lifting, bubbling, or edge contamination, which can harbour particles in clean environments. Because ink is deposited in a thicker, more uniform layer than most digital or flexo-printed labels, opacity and colour density are superior—crucial for high-contrast warnings, graduated scales, and serialization areas requiring reliable code reading. The fused ink film withstands friction in filling lines, repeated cap opening, and exposure to light or humidity better than many adhesive labels or shrink sleeves, which can tear or delaminate.
While labels and sleeves remain useful for variable data or full-coverage graphics, Steba can engineer hybrid solutions—combining screen-printed core information with complementary decoration methods. This approach maintains the robustness of direct print on the jar surface while adding design flexibility where the project demands more complex visual elements.
Regulatory, Quality, and Traceability Requirements
Compliance of Plastic Jars with Pharma Standards
Pharmaceutical plastic jars classified as primary packaging must comply with EU GMP Part I & II, Annex 1 (where applicable), and relevant pharmacopoeias (Ph. Eur., USP < 661. 1>, < 661. 2>). Materials in contact with medicines require extractables and leachables assessments and must respect specific migration limits under ICH and EMA guidelines. Cleanroom-controlled molding, filtered air, and controlled handling minimize particulate and microbiological contamination. Each jar format is validated as part of the medicinal product’s regulatory dossier, including dimensional conformity, closure integrity, and compatibility with filling lines. Steba supports this by providing complete technical files, DMF-style data on polymers and additives, certificates of conformity for each batch, and full material traceability from resin lot to finished jar, enabling straightforward inclusion in regulatory submissions.
Printed Information: Legibility, Durability, and Safety
Regulators expect clear, permanent identification of product name, dosage strength, batch number, and expiry date according to EU labelling rules and national requirements. Screen-printed data must resist rubbing, alcohol-based disinfectants, and moisture typically encountered in pharmacies and hospital wards. High-contrast color combinations and optional tactile symbols help differentiate strengths and highlight critical warnings, supporting medication safety. Steba validates print performance through in-house protocols that simulate repeated handling, cleaning cycles, and light exposure, checking optical density, color stability, and barcode readability. These tests are tailored to pharma risk assessments, with documented results available for customer qualification files.
Quality Systems, Audits, and Documentation
ISO 9001-based quality management, reinforced by pharma-oriented SOPs, governs every step of jar and print production. Batch records trace raw materials, machine settings, and inspection results; in-process controls verify print registration, color consistency, and code accuracy; final inspections release only conforming lots. Customer audits, technical visits, and periodic quality reviews are integral to supplier qualification. Steba’s Italian facilities maintain audit-ready documentation, CAPA-driven continuous improvement, and dedicated QA contacts, supporting long-term, compliant partnerships with pharmaceutical companies.
Branding, Design, and Supply-Chain Benefits of Italian Screen-Printed Jars
Brand Identity and Patient Experience
Screen-printed plastic jars act as miniature billboards, using calibrated color, typography, and layout to make pharmaceutical brands instantly recognizable on crowded pharmacy shelves. Clear hierarchies of information—dose, product name, key warnings—can be structured through font size, contrast, and zoning, improving patient comprehension and adherence. Italian screen-printing enables premium tactile and visual finishes such as soft-touch matte, high-gloss panels, and spot colors that highlight critical data while elevating perceived quality and trust. Steba supports pharma teams with design and pre-press services, checking line weights, trapping, ink opacity, and print tolerances so that brand guidelines are translated into technically robust, compliant artwork ready for industrial screen-printing.
Made in Italy as a Value Driver
“Made in Italy” is widely associated with precision, reliability, and design excellence—attributes that strengthen pharmaceutical brand positioning. Local European production shortens lead times, eases communication in multiple languages, and supports alignment with EU regulatory expectations on labeling and materials. Italian manufacturing know-how contributes to consistent, high-end finishes across large batches, minimizing color drift and registration issues. Steba leverages its Italian roots to provide responsive project management, rapid sampling, and flexible production slots for European and global clients needing agile launches or line extensions.
Supply-Chain Optimization and Sustainability
Sourcing jars and screen-printing from a single Italian partner reduces supplier interfaces, simplifies quality audits, and lowers coordination risk. A stable production base allows tailored inventory models—just-in-time for fast movers, safety stocks for critical SKUs—backed by reliable replenishment. Environmental performance improves through lightweight jar designs, recyclable polymers, and efficient, low-waste printing processes. Acting as a one-stop provider, Steba coordinates jar manufacturing, decoration, and delivery, consolidating shipments and documentation to streamline the pharmaceutical customer’s overall supply chain.
Conclusion
Properly engineered pharmaceutical plastic jars, paired with precise screen-printing, are essential to protect formulations, support correct usage, and strengthen brand recognition. When these elements are developed within the Italian manufacturing tradition, they gain additional value through meticulous design, dimensional accuracy, and deep regulatory awareness.
Steba brings these strengths together in complete “Made in Italy” solutions, supplying pharmaceutical-grade plastic jars, advanced screen-printing, and all necessary compliant documentation. Pharmaceutical and nutraceutical companies seeking packaging that is safe, distinctive, and fully aligned with current standards can rely on Steba as a specialized partner. Contact Steba to develop tailored, compliant, and brand-enhancing packaging projects that support both product integrity and market positioning.